Simon Høj

Biologic-assisted house dust mite immunotherapy in allergic asthma: could it provide a bridge toward de-escalation?

To the Editor,We read with great interest the three-year randomized study by Bozek and colleagues comparing omalizumab, subcutaneous house dust mite allergen immunotherapy (HDM-SCIT), their combina...